You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2011 or most recent year available
Part (iv) All inpatient clients, ratio of males to females by country and primary drug
| Country | Opioids | Cocaine | Stimulants | Hypnotics and sedatives | Hallucinogens | Volatile substances | Cannabis | Other drugs | Gender and drug known | |
|---|---|---|---|---|---|---|---|---|---|---|
| Belgium | 4.7 | 3.9 | 4.3 | 1.1 | : | 0.0 | 3.8 | 1.6 | 1339 | |
| Bulgaria | 6.5 | : | : | : | : | : | : | : | 342 | |
| Czech Republic | 2.0 | 2.0 | 1.8 | 2.6 | : | 9.0 | 3.8 | 1.2 | 2315 | |
| Denmark | 4.4 | 1.8 | 2.4 | 3.0 | : | : | 4.9 | 0.5 | 154 | |
| Germany | 4.2 | 7.0 | 3.3 | 0.6 | 5.6 | 2.0 | 6.1 | 4.0 | 8050 | |
| Estonia | : | : | : | : | : | : | : | : | : | |
| Ireland | 1 | 1.6 | 4.5 | 2.8 | 0.6 | 1.0 | : | 3.4 | 1.6 | 1195 |
| Greece | 5.6 | 11.3 | : | 3.7 | 1.0 | : | 7.5 | 2.0 | 1571 | |
| Spain | : | : | : | : | : | : | : | : | : | |
| France | 3.1 | 5.3 | : | 2.7 | : | : | 6.1 | : | 678 | |
| Italy | : | : | : | : | : | : | : | : | : | |
| Cyprus | 2 | 8.5 | 5.7 | 1.0 | 1.5 | : | : | : | : | 156 |
| Latvia | : | : | : | : | : | : | : | : | : | |
| Lithuania | : | : | : | : | : | : | : | : | : | |
| Luxembourg | 2.7 | 3.2 | : | : | : | : | 15.0 | : | 128 | |
| Hungary | 3 | 3.4 | : | 5.8 | 1.6 | : | : | 13.0 | 2.6 | 295 |
| Malta | : | : | : | : | : | : | : | : | : | |
| Netherlands | 3.7 | 5.5 | 3.3 | 1.8 | 3.0 | : | 3.9 | 1.1 | 1768 | |
| Austria | 3.1 | 7.4 | 2.7 | 2.3 | : | : | 4.9 | 0.0 | 1168 | |
| Poland | 4 | 6.6 | 5.0 | 5.6 | 1.9 | : | : | 7.5 | : | 545 |
| Portugal | : | : | : | : | : | : | : | : | : | |
| Romania | 5 | 2.6 | 3.0 | 0.8 | 0.7 | 1.0 | : | 5.4 | 3.3 | 983 |
| Slovenia | : | : | : | : | : | : | : | : | : | |
| Slovakia | 2.7 | 2.0 | 3.5 | 0.9 | : | 6.1 | 8.5 | : | 670 | |
| Finland | 1.9 | : | 1.6 | 1.5 | : | 1.0 | 2.4 | : | 535 | |
| Sweden | : | : | : | : | : | : | : | : | : | |
| United Kingdom | 6 | 2.7 | 2.3 | 2.1 | 1.8 | 1.7 | 1.0 | 3.4 | : | 3727 |
| Croatia | 3.5 | 2.3 | 2.0 | 0.8 | 1.7 | : | 5.7 | 3.3 | 563 | |
| Turkey | 13.4 | 22.0 | 18.0 | 2.2 | : | 35.5 | 23.2 | 3.4 | 2115 | |
| Norway | 7 | 2.1 | 9.0 | 2.1 | 0.8 | 3.0 | 0.0 | 3.4 | 2.2 | 3921 |
| Total | 3.5 | 4.6 | 2.5 | 1.0 | 3.3 | 12.8 | 5.2 | 2.9 | 3 | |
| Total base | 14811 | 2257 | 4250 | 1715 | 107 | 248 | 5462 | 3368 | 32218 |
Notes:
Empty cells correspond to instances where no female case has been reported. In such instances, the number of male cases also tends to be small or zero, but if the number of male clients exceeds 5 units, then a specific note is presented. Ratios equal to zero correspond to instances where no male cases have been reported while female cases have been reported. In such instances, the number of female cases tends also to be small, but if the number of female client exceeds 5 units, then a specific note is presented.
1 - Data are from 2010.
2 - 32 Male Cannabis clients reported.
3 - 6 Male Volatile and Inhalant clients reported.
4 - Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.
5 - 9 Male Volatile and Inhalant clients reported.
6 - Data are from 1st of April 2010 to 31st March 2011.
7 - In Norway the criteria for selecting and grouping cases are main ICD-10 diagnosis codes F11-F16 and F18-F19.
For more information relative to the treatment centre type, please see Table TDI-7.
See also 'General notes for interpreting data’ on the Explanatory notes and help page.
Source:
Reitox national reports 2012 — TDI — inpatient treatment centres.